Skip to main content

Animations

MJFF Publications

5591 - 5600 of 8816 Results
Title
Year
  • Year
  • 2020
  • 2017
  • 2006
  • 2024
  • 2010
  • 2021
  • 2015
  • 2020
  • 2017
  • 2025
  • Summary Details
    RESTRICTED
    Title: CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28056
    Citation Count: 66
  • Summary Details
    RESTRICTED
    Title: Biomarkers for cognitive dysfunction in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.023
    Citation Count: 50
  • Summary Details
    RESTRICTED
    Title: Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fj.03-1449com
    Citation Count: 692
  • Summary Details
    RESTRICTED
    Title: On‐Demand Cueing for Freezing of Gait in Parkinson's Disease: A Randomized Controlled Trial
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29762
    Citation Count: 13
  • Summary Details
    OPEN
    Title: CSF Aβ42 and tau in Parkinson's disease with cognitive impairment
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23287
    Citation Count: 176
  • Summary Details
    OPEN
    Title: A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalography
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-021-99167-2
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Current disease modifying approaches to treat Parkinson’s disease
    Journal Name: Cellular and Molecular Life Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00018-015-2101-1
    Citation Count: 95
  • Summary Details
    OPEN
    Title: Structure–Functional–Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased Ligands
    Journal Name: ACS Medicinal Chemistry Letters
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsmedchemlett.9b00575
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Changes in kynurenine pathway metabolism in Parkinson patients with L‐DOPA‐induced dyskinesia
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.14104
    Citation Count: 105
  • Summary Details
    OPEN
    Title: A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stage
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.107018
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.